Eli Lilly (NYSE: LLY), a pharmaceutical giant with a market cap of $658 billion, has achieved impressive growth in recent years, primarily driven by its diabetes drugs, Mounjaro and Trulicity. But with a current stock price of $732, is Eli Lilly overvalued, or does it present an opportunity for long-term investors? Let’s break down the numbers and evaluate its valuation.

When it comes to the pharmaceutical industry, Pfizer stands tall as a legacy company with a rich history of innovation. However, its recent financial performance and stock price movements have left investors questioning its valuation. At a market cap of $124 billion and a trading price of $22 per share, is Pfizer undervalued, or does the dip signal deeper challenges?

Investing in pharmaceutical stocks often means betting on innovation and consistent cash flow. With a strong market presence and a robust portfolio, Sanofi is no exception. But is it currently undervalued or an opportunity waiting to be seized? In this detailed analysis, we’ll dissect Sanofi’s financial statements and ratios to determine whether this large-cap stock should be on your radar.

In the ever-evolving world of investing, evaluating stocks to determine their worth and potential can be as thrilling as a game of chance at a casino. Boyd Gaming Corporation (NYSE: BYD), a prominent player in the gaming and hospitality industry, is no exception.

The cryptocurrency landscape is no stranger to volatility, but recent developments in the Bitcoin mining sector have sparked heated debates among investors. With miners like CleanSpark making controversial strategic shifts and MicroStrategy steadfastly holding its Bitcoin, the industry is at a pivotal crossroads.

When economic uncertainties arise, investors tend to react by selling stocks across the board. Yet, there are companies that not only weather recessions but thrive during them. **HIMS & HERS Health Inc.**, a telehealth pioneer, stands out as one such example. Here's why HIMS remains a compelling investment, even in the face of economic downturns.

Pfizer Inc. (NYSE: PFE) has experienced a dramatic decline in its stock price, plummeting 63% from its all-time high. With the dividend yield now approaching 8%, many investors are evaluating whether this is a lucrative buying opportunity or a potential trap.

Apple Inc. (NASDAQ: AAPL) has seen a notable pullback in its stock price, dropping 23% year-to-date and over 17.5% in the last month. This decline is sparking questions among investors: is Apple presenting a generational buying opportunity, or is it still overvalued amid tariff-related challenges?

Economic uncertainties often spark debates around the most resilient stocks in the face of inflation and evolving tariff policies. Amid such volatility, Visa Inc. (NYSE: V) emerges as a standout player, not just surviving but thriving in inflationary periods.

In recent times, SoFi Technologies Inc. (NASDAQ: SOFI) has witnessed a sharp decline in its stock price. From trading at $18 to falling below $10, investors are faced with questions about what lies ahead in a market riddled with volatility.

stock market commentary

Corey Kramer, host of the Cyclical Investors Club YouTube channel, recently shared his insights on Advanced Micro Devices (ticker: AMD). Known for its pivotal role in the semiconductor industry, AMD presents a textbook example of a deeply cyclical business.

Alphabet Inc., the parent company of Google, is among the most prominent businesses in the technology sector. Corey Kramer, from the Cyclical Investors Club YouTube channel, recently shared his analysis of the stock, focusing on GOOGL ticker.

Deckers Outdoor Corp, an innovative force in the footwear and apparel industry, has recently garnered attention from Corey Kramer, host of the Cyclical Investors Club YouTube channel.

Micron Technology, a prominent player in the semiconductor industry, has recently faced notable price fluctuations, particularly in the wake of newly implemented tariffs.

Flowers Foods is a name that rarely gets mentioned when discussing high-performing dividend stocks. Yet, the company's all-time total return since its IPO is a staggering 40,000%!

Oshkosh Corporation (ticker symbol: OSK) may not always grab headlines, but this industrial equipment powerhouse is quietly making waves as an undervalued dividend-paying stock with solid financials and promising growth prospects.

The S&P 500 has been a cornerstone of the stock market for decades, reflecting the performance of 500 of the largest publicly traded companies in the United States. If you've been paying attention to market trends over the past year, you've likely heard discussions about its Price-to-Earnings (P/E) ratio.

Philip Morris International (PMI) is not your average tobacco company. While many perceive tobacco stocks as relics of the past, PMI has embarked on a radical transformation.

Stock Market Commentary